Pneumococcal Conjugate Vaccines in Infants and Children Under 5 Years of Age: WHO Position Paper – February 2019
This article, published in the Weekly Epidemiological Record, summarizes the World Health Organization's (WHO's) recommendations on pneumococcal conjugate vaccines (PCVs) and related issues, including epidemiology, disease characteristics, and PCV safety, efficacy, and effectiveness. This 2019 update replaces the WHO's 2012 position paper on pneumococcal vaccines and focuses on PCVs in infants and children less than five years of age. It includes data on the effects of the 10- and 13-valent PCVs published up to June 2017 and specifically addresses the dosing schedule, product choice, and the value of catch-up vaccination in children under five years of age.
Author: World Health Organization
» Download file (English, French)
515 KB PDF (Located at apps.who.int)
Also known as: Vaccins antipneumococciques conjugués chez les nourrissons et les enfants de moins de 5 ans: note de synthèse de l’OMS – février 2019
Resource types: Newsletter/article